2009
DOI: 10.1186/1471-2407-9-258
|View full text |Cite
|
Sign up to set email alerts
|

Role of KCNMA1gene in breast cancer invasion and metastasis to brain

Abstract: BackgroundThe prognosis for patients with breast tumor metastases to brain is extremely poor. Identification of prognostic molecular markers of the metastatic process is critical for designing therapeutic modalities for reducing the occurrence of metastasis. Although ubiquitously present in most human organs, large-conductance calcium- and voltage-activated potassium channel (BKCa) channels are significantly upregulated in breast cancer cells. In this study we investigated the role of KCNMA1 gene that encodes … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

5
72
0

Year Published

2011
2011
2019
2019

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 109 publications
(78 citation statements)
references
References 26 publications
5
72
0
Order By: Relevance
“…Evidence is particularly extensive for Ca 2+ and K + channels [93] and Romania et al already described their importance in neuroblastoma [94]. In our analysis, several genes coding for Ca 2+ and K + channels were altered in CSC-like subpopulation like KCNMA1 , previously described in prostate cancer [95] and in breast cancer [96], [97], and CACN1AG also altered in gastric cancers, colorectal cancers and acute myeloid leukemia (AML) [98]. Several reports propose that ion transporters have clinical potential not only as therapeutical targets but also as prognosis markers or to improve actual treatments [99][103], as blocking channel activity seems to impair the growth of some tumors, including neuroblastoma [99], [104].…”
Section: Discussionsupporting
confidence: 73%
“…Evidence is particularly extensive for Ca 2+ and K + channels [93] and Romania et al already described their importance in neuroblastoma [94]. In our analysis, several genes coding for Ca 2+ and K + channels were altered in CSC-like subpopulation like KCNMA1 , previously described in prostate cancer [95] and in breast cancer [96], [97], and CACN1AG also altered in gastric cancers, colorectal cancers and acute myeloid leukemia (AML) [98]. Several reports propose that ion transporters have clinical potential not only as therapeutical targets but also as prognosis markers or to improve actual treatments [99][103], as blocking channel activity seems to impair the growth of some tumors, including neuroblastoma [99], [104].…”
Section: Discussionsupporting
confidence: 73%
“…Abdallah Mound et al recently found that ATP induced cell proliferation could be effectively blocked in MCF-7 cells by downregulation of BKCa [10]. Another study showed that downregulation of BKCa significantly reduced invasion and transendothelial migration of breast cancer cells [13]. In melanoma, BKCa encoding gene KCNMA1 was found to be the target of miRNA-211.…”
Section: Discussionmentioning
confidence: 99%
“…211,212 In this section we will briefly discuss some of these findings that link BK channels with the diseases in which they play a major role.…”
Section: Bk Channels and Diseases Pathophysiological And Genetic Invmentioning
confidence: 99%
“…3C). 212 Amplifications of the BK channel gene have also been observed in many types of prostate cancers. 243 The study of BK channels in prostate cancer has shown that BK channels open at resting potentials and low intracellular Ca 2+ , 244 thus paving the way to find γ subunits.…”
mentioning
confidence: 99%